Drug Information

Drug General Information
Drug ID
D0E2MI
Former ID
DIB003123
Drug Name
ARH-1029
Synonyms
AR-HP; Dual-acting H. pylori therapeutic (peptic ulcer disease), CJ Corp; Dual-acting H. pylori therapeutic, (peptic ulcer disease), Taiho Pharmaceutical
Indication Helicobacter pylori infection [ICD9: 41.86; ICD10:B96.81] Investigative [543965]
Company
ARigen Pharmaceuticals Inc
Target and Pathway
Target(s) Potassium-transporting ATPase alpha chain 1 Target Info Modulator [543965]
KEGG Pathway Oxidative phosphorylation
Collecting duct acid secretion
Gastric acid secretion
PathWhiz Pathway Gastric Acid Production
Reactome Ion transport by P-type ATPases
WikiPathways Iron uptake and transport
Secretion of Hydrochloric Acid in Parietal Cells
References
Ref 543965(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 849).
Ref 543965(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 849).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.